Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712484
What this trial is testing
A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of Care
Who this might be right for
CoccidioidomycosisDisseminated Fungal InfectionCoccidioides Infection+5 more
F2G Ltd 50